IFG
VRTX icon

Independent Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Independent Financial Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$668K Buy
1,345
+173
+15% +$76.7K 0.01% 856
2026
Q1 		$523K Buy
1,172
+103
+10% +$48K 0.01% 913
2025
Q4 		$485K Sell
1,069
-122
-10% -$52.6K 0.01% 916
2025
Q3 		$466K Sell
1,191
-155
-12% -$64.8K 0.01% 890
2025
Q2 		$599K Sell
1,346
-993
-42% -$458K 0.02% 702
2025
Q1 		$1.13M Buy
2,339
+694
+42% +$323K 0.04% 450
2024
Q4 		$662K Sell
1,645
-414
-20% -$192K 0.02% 608
2024
Q3 		$958K Buy
2,059
+462
+29% +$222K 0.04% 453
2024
Q2 		$749K Sell
1,597
-263
-14% -$114K 0.03% 478
2024
Q1 		$777K Buy
1,860
+614
+49% +$260K 0.04% 449
2023
Q4 		$507K Sell
1,246
-49
-4% -$18.1K 0.03% 549
2023
Q3 		$450K Sell
1,295
-218
-14% -$76.2K 0.03% 526
2023
Q2 		$532K Buy
1,513
+13
+0.9% +$4.38K 0.04% 468
2023
Q1 		$473K Sell
1,500
-32
-2% -$9.6K 0.04% 468
2022
Q4 		$442K Sell
1,532
-84
-5% -$25.6K 0.04% 450
2022
Q3 		$468K Sell
1,616
-153
-9% -$44K 0.04% 411
2022
Q2 		$498K Sell
1,769
-163
-8% -$43.6K 0.05% 389
2022
Q1 		$504K Buy
1,932
+413
+27% +$98K 0.04% 430
2021
Q4 		$334K Sell
1,519
-25
-2% -$4.86K 0.03% 551
2021
Q3 		$280K Buy
1,544
+70
+5% +$13.7K 0.03% 549
2021
Q2 		$297K Buy
1,474
+225
+18% +$47.1K 0.03% 535
2021
Q1 		$268K Buy
1,249
+117
+10% +$25.7K 0.03% 501
2020
Q4 		$268K Buy
1,132
+210
+23% +$48.2K 0.04% 451
2020
Q3 		$251K Buy
922
+204
+28% +$56.3K 0.05% 390
2020
Q2 		$208K Buy
+718
New +$195K 0.05% 407

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Independent Financial Group's VRTX Position: Q2 2026 in Review

Independent Financial Group increased its Vertex Pharmaceuticals (VRTX) stake by 15% in Q2 2026, buying an estimated $76.7K and bringing the position to 1,345 shares worth $668K. The position accounts for 0.01% of the portfolio, ranked #856.

Independent Financial Group first reported a position in VRTX in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.13M in Q1 2025. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Independent Financial Group held 1,345 shares of Vertex Pharmaceuticals worth $668K as of Q2 2026.
  • Independent Financial Group bought 173 Vertex Pharmaceuticals shares in Q2 2026, an estimated $76.7K.
  • Vertex Pharmaceuticals made up 0.01% of Independent Financial Group's portfolio in Q2 2026, its #856 holding.
  • Independent Financial Group first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 25 quarters since.
  • Independent Financial Group's Vertex Pharmaceuticals position peaked at $1.13M in Q1 2025.
  • 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Independent Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.